fanta.bio Sample: CNhs11790
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
18913 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2373 / 19934 (11.9%) | 1080 / 199340 (0.5%) | −324.0 | −324.0 | 21.97 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1036 / 19934 (5.2%) | 558 / 199340 (0.3%) | −324.0 | −324.0 | 18.57 |
| HIF1A SRX20663235 | HK-2 Kidney | 544 / 19934 (2.7%) | 320 / 199340 (0.2%) | −324.0 | −324.0 | 17.00 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1600 / 19934 (8.0%) | 984 / 199340 (0.5%) | −324.0 | −324.0 | 16.26 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2230 / 19934 (11.2%) | 1424 / 199340 (0.7%) | −324.0 | −324.0 | 15.66 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2286 / 19934 (11.5%) | 1463 / 199340 (0.7%) | −324.0 | −324.0 | 15.63 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1468 / 19934 (7.4%) | 976 / 199340 (0.5%) | −324.0 | −324.0 | 15.04 |
| SCML2 SRX644728 | 293 Kidney | 1372 / 19934 (6.9%) | 924 / 199340 (0.5%) | −324.0 | −324.0 | 14.85 |
| FOXP1 SRX736067 | LNCAP Prostate | 1819 / 19934 (9.1%) | 1396 / 199340 (0.7%) | −324.0 | −324.0 | 13.03 |
| BRD4 SRX9419935 | BT-474 Breast | 3706 / 19934 (18.6%) | 3289 / 199340 (1.6%) | −324.0 | −324.0 | 11.27 |
| MED1 SRX9419945 | BT-474 Breast | 3695 / 19934 (18.5%) | 3305 / 199340 (1.7%) | −324.0 | −324.0 | 11.18 |
| MED1 SRX9419944 | BT-474 Breast | 3612 / 19934 (18.1%) | 3267 / 199340 (1.6%) | −324.0 | −324.0 | 11.06 |
| BRD4 SRX9419937 | BT-474 Breast | 3677 / 19934 (18.4%) | 3328 / 199340 (1.7%) | −324.0 | −324.0 | 11.05 |
| BRD4 SRX9419938 | BT-474 Breast | 3739 / 19934 (18.8%) | 3462 / 199340 (1.7%) | −324.0 | −324.0 | 10.80 |
| MED1 SRX9419946 | BT-474 Breast | 3745 / 19934 (18.8%) | 3483 / 199340 (1.7%) | −324.0 | −324.0 | 10.75 |
| BRD4 SRX9419936 | BT-474 Breast | 3747 / 19934 (18.8%) | 3490 / 199340 (1.8%) | −324.0 | −324.0 | 10.74 |
| MED1 SRX9419947 | BT-474 Breast | 3640 / 19934 (18.3%) | 3410 / 199340 (1.7%) | −324.0 | −324.0 | 10.67 |
| MYH11 SRX265221 | ME-1 Blood | 781 / 19934 (3.9%) | 781 / 199340 (0.4%) | −324.0 | −324.0 | 10.00 |
| EZH2 SRX2146136 | LNCAP Prostate | 8150 / 19934 (40.9%) | 9467 / 199340 (4.7%) | −324.0 | −324.0 | 8.61 |
| BRD4 SRX736201 | 90-8TL Neural | 5767 / 19934 (28.9%) | 8003 / 199340 (4.0%) | −324.0 | −324.0 | 7.21 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1845 / 19934 (9.3%) | 3213 / 199340 (1.6%) | −324.0 | −324.0 | 5.74 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2076 / 19934 (10.4%) | 5837 / 199340 (2.9%) | −324.0 | −324.0 | 3.56 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1038 / 19934 (5.2%) | 27849 / 199340 (14.0%) | −324.0 | −324.0 | 0.37 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1036 / 19934 (5.2%) | 28738 / 199340 (14.4%) | −324.0 | −324.0 | 0.36 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1017 / 19934 (5.1%) | 28929 / 199340 (14.5%) | −324.0 | −324.0 | 0.35 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 678 / 19934 (3.4%) | 22248 / 199340 (11.2%) | −324.0 | −324.0 | 0.30 |
| PBX4 SRX2731658 | PC-3 Prostate | 937 / 19934 (4.7%) | 31653 / 199340 (15.9%) | −324.0 | −324.0 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 628 / 19934 (3.2%) | 24191 / 199340 (12.1%) | −324.0 | −324.0 | 0.26 |
| FOS SRX150517 | MCF 10A Breast | 487 / 19934 (2.4%) | 19113 / 199340 (9.6%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 585 / 19934 (2.9%) | 23597 / 199340 (11.8%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757325 | H2052 Lung | 572 / 19934 (2.9%) | 24458 / 199340 (12.3%) | −324.0 | −324.0 | 0.23 |
| FOS SRX4192880 | MCF 10A Breast | 445 / 19934 (2.2%) | 19143 / 199340 (9.6%) | −324.0 | −324.0 | 0.23 |
| YAP1 SRX757326 | H2052 Lung | 485 / 19934 (2.4%) | 21872 / 199340 (11.0%) | −324.0 | −324.0 | 0.22 |
| JUN SRX17561461 | LPS141 Adipocyte | 393 / 19934 (2.0%) | 17176 / 199340 (8.6%) | −322.6 | −319.6 | 0.23 |
| SS18 SRX3468047 | Fibroblasts Others | 809 / 19934 (4.1%) | 24090 / 199340 (12.1%) | −319.5 | −316.5 | 0.34 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 753 / 19934 (3.8%) | 23147 / 199340 (11.6%) | −317.6 | −314.7 | 0.33 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1148 / 19934 (5.8%) | 28898 / 199340 (14.5%) | −310.4 | −307.5 | 0.40 |
| JUNB SRX8488088 | SUM 229PE Breast | 597 / 19934 (3.0%) | 20353 / 199340 (10.2%) | −309.7 | −306.7 | 0.29 |
| RUNX1 SRX2513054 | 293 Kidney | 3974 / 19934 (19.9%) | 20758 / 199340 (10.4%) | −306.2 | −303.2 | 1.91 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 956 / 19934 (4.8%) | 25882 / 199340 (13.0%) | −305.4 | −302.5 | 0.37 |
| JUNB SRX8488073 | SUM 229PE Breast | 583 / 19934 (2.9%) | 19969 / 199340 (10.0%) | −304.8 | −301.9 | 0.29 |
| FOS SRX150476 | MCF 10A Breast | 539 / 19934 (2.7%) | 19191 / 199340 (9.6%) | −303.8 | −300.9 | 0.28 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 624 / 19934 (3.1%) | 20300 / 199340 (10.2%) | −293.9 | −291.0 | 0.31 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2590 / 19934 (13.0%) | 11236 / 199340 (5.6%) | −291.1 | −288.2 | 2.31 |
| GATA3 SRX190194 | SK-N-SH Neural | 800 / 19934 (4.0%) | 22979 / 199340 (11.5%) | −290.0 | −287.1 | 0.35 |
| JUN SRX6582171 | GM07492 Others | 631 / 19934 (3.2%) | 20265 / 199340 (10.2%) | −289.2 | −286.4 | 0.31 |
| FOXA1 SRX4815197 | MCF-7 Breast | 856 / 19934 (4.3%) | 23712 / 199340 (11.9%) | −286.2 | −283.4 | 0.36 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 709 / 19934 (3.6%) | 21378 / 199340 (10.7%) | −284.8 | −281.9 | 0.33 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1791 / 19934 (9.0%) | 6295 / 199340 (3.2%) | −284.6 | −281.8 | 2.85 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 643 / 19934 (3.2%) | 20153 / 199340 (10.1%) | −279.7 | −276.9 | 0.32 |
| SMARCA2 SRX8119677 | MeT-5A Others | 527 / 19934 (2.6%) | 18232 / 199340 (9.1%) | −279.4 | −276.6 | 0.29 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 564 / 19934 (2.8%) | 18834 / 199340 (9.4%) | −279.0 | −276.2 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 503 / 19934 (2.5%) | 17752 / 199340 (8.9%) | −277.1 | −274.3 | 0.28 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 399 / 19934 (2.0%) | 15904 / 199340 (8.0%) | −276.0 | −273.2 | 0.25 |
| TCF12 SRX190356 | SK-N-SH Neural | 967 / 19934 (4.9%) | 25003 / 199340 (12.5%) | −275.3 | −272.5 | 0.39 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1430 / 19934 (7.2%) | 4410 / 199340 (2.2%) | −271.8 | −269.1 | 3.24 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 450 / 19934 (2.3%) | 16655 / 199340 (8.4%) | −271.1 | −268.3 | 0.27 |
| FOXA1 SRX176862 | MCF-7 Breast | 448 / 19934 (2.2%) | 16556 / 199340 (8.3%) | −269.0 | −266.3 | 0.27 |
| FOXA1 SRX176863 | MCF-7 Breast | 405 / 19934 (2.0%) | 15794 / 199340 (7.9%) | −268.8 | −266.0 | 0.26 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 312 / 19934 (1.6%) | 14036 / 199340 (7.0%) | −266.8 | −264.0 | 0.22 |
| FOS SRX4192879 | MCF 10A Breast | 365 / 19934 (1.8%) | 15011 / 199340 (7.5%) | −266.6 | −263.9 | 0.24 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 596 / 19934 (3.0%) | 18916 / 199340 (9.5%) | −265.1 | −262.4 | 0.32 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 441 / 19934 (2.2%) | 16148 / 199340 (8.1%) | −259.8 | −257.1 | 0.27 |
| JUNB SRX8488074 | SUM 229PE Breast | 444 / 19934 (2.2%) | 16169 / 199340 (8.1%) | −258.8 | −256.1 | 0.27 |
| JUNB SRX10119386 | MCF 10A Breast | 273 / 19934 (1.4%) | 13037 / 199340 (6.5%) | −258.0 | −255.3 | 0.21 |
| FOSL2 SRX190296 | SK-N-SH Neural | 448 / 19934 (2.2%) | 16165 / 199340 (8.1%) | −256.4 | −253.7 | 0.28 |
| PRRX1 SRX15235713 | Hs 578T Breast | 396 / 19934 (2.0%) | 15251 / 199340 (7.7%) | −256.3 | −253.6 | 0.26 |
| AR SRX1067071 | LHSAR Prostate | 719 / 19934 (3.6%) | 20573 / 199340 (10.3%) | −256.0 | −253.3 | 0.35 |
| 5-mC SRX882970 | LNCAP Prostate | 3406 / 19934 (17.1%) | 17828 / 199340 (8.9%) | −255.5 | −252.8 | 1.91 |
| SMARCA4 SRX5212362 | Mel270 Others | 606 / 19934 (3.0%) | 18764 / 199340 (9.4%) | −255.5 | −252.8 | 0.32 |
| ESR1 SRX4367193 | MCF-7 Breast | 1240 / 19934 (6.2%) | 28209 / 199340 (14.2%) | −255.4 | −252.8 | 0.44 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 286 / 19934 (1.4%) | 13183 / 199340 (6.6%) | −254.4 | −251.8 | 0.22 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 844 / 19934 (4.2%) | 22345 / 199340 (11.2%) | −252.0 | −249.3 | 0.38 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1097 / 19934 (5.5%) | 25993 / 199340 (13.0%) | −250.3 | −247.6 | 0.42 |
| FOXA1 SRX371482 | MCF-7 Breast | 525 / 19934 (2.6%) | 17268 / 199340 (8.7%) | −250.2 | −247.6 | 0.30 |
| ESR1 SRX7624157 | MCF-7 Breast | 988 / 19934 (5.0%) | 24411 / 199340 (12.2%) | −250.1 | −247.5 | 0.40 |
| JUN SRX6582172 | Fibroblasts Others | 453 / 19934 (2.3%) | 16048 / 199340 (8.1%) | −250.0 | −247.4 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 810 / 19934 (4.1%) | 21734 / 199340 (10.9%) | −249.2 | −246.6 | 0.37 |
| FOXA1 SRX1161177 | MCF-7 Breast | 360 / 19934 (1.8%) | 14384 / 199340 (7.2%) | −248.9 | −246.2 | 0.25 |
| YAP1 SRX5718140 | 293 Kidney | 617 / 19934 (3.1%) | 18721 / 199340 (9.4%) | −248.8 | −246.2 | 0.33 |
| CIC SRX13262055 | Astrocytes Neural | 3601 / 19934 (18.1%) | 19517 / 199340 (9.8%) | −247.4 | −244.8 | 1.85 |
| ESR1 SRX371478 | MCF-7 Breast | 471 / 19934 (2.4%) | 16265 / 199340 (8.2%) | −247.2 | −244.6 | 0.29 |
| EP300 SRX2671813 | Fibroblasts Others | 261 / 19934 (1.3%) | 12485 / 199340 (6.3%) | −247.0 | −244.4 | 0.21 |
| 5-mC SRX882968 | LNCAP Prostate | 3358 / 19934 (16.8%) | 17699 / 199340 (8.9%) | −246.9 | −244.3 | 1.90 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 459 / 19934 (2.3%) | 16052 / 199340 (8.1%) | −246.8 | −244.2 | 0.29 |
| JUNB SRX4192882 | MCF 10A Breast | 244 / 19934 (1.2%) | 12136 / 199340 (6.1%) | −246.4 | −243.8 | 0.20 |
| SMARCA4 SRX5212357 | Mel270 Others | 510 / 19934 (2.6%) | 16873 / 199340 (8.5%) | −245.8 | −243.2 | 0.30 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 950 / 19934 (4.8%) | 23694 / 199340 (11.9%) | −245.6 | −243.0 | 0.40 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2114 / 19934 (10.6%) | 8973 / 199340 (4.5%) | −244.5 | −241.9 | 2.36 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 331 / 19934 (1.7%) | 13717 / 199340 (6.9%) | −244.3 | −241.7 | 0.24 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 465 / 19934 (2.3%) | 16060 / 199340 (8.1%) | −243.8 | −241.3 | 0.29 |
| SMARCA4 SRX5212366 | Mel270 Others | 473 / 19934 (2.4%) | 16158 / 199340 (8.1%) | −242.7 | −240.2 | 0.29 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 642 / 19934 (3.2%) | 18899 / 199340 (9.5%) | −242.2 | −239.7 | 0.34 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 478 / 19934 (2.4%) | 16170 / 199340 (8.1%) | −240.4 | −237.8 | 0.30 |
| GATA3 SRX190239 | MCF-7 Breast | 554 / 19934 (2.8%) | 17425 / 199340 (8.7%) | −240.4 | −237.8 | 0.32 |
| TP53 SRX19538279 | Osteoblasts Bone | 446 / 19934 (2.2%) | 366 / 199340 (0.2%) | −240.1 | −237.5 | 12.19 |
| AR SRX1067070 | LHSAR Prostate | 950 / 19934 (4.8%) | 23480 / 199340 (11.8%) | −239.8 | −237.2 | 0.40 |
| YAP1 SRX10119364 | MCF 10A Breast | 271 / 19934 (1.4%) | 12427 / 199340 (6.2%) | −238.4 | −235.9 | 0.22 |
| JUN SRX4192884 | MCF 10A Breast | 273 / 19934 (1.4%) | 12460 / 199340 (6.3%) | −238.2 | −235.7 | 0.22 |
| VGLL1 SRX24602130 | BT-20 Breast | 360 / 19934 (1.8%) | 14035 / 199340 (7.0%) | −237.5 | −235.0 | 0.26 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 376 / 19934 (1.9%) | 14293 / 199340 (7.2%) | −236.6 | −234.1 | 0.26 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1426 / 19934 (7.2%) | 30028 / 199340 (15.1%) | −236.5 | −233.9 | 0.47 |
| AGO2 SRX4708039 | Hep G2 Liver | 2080 / 19934 (10.4%) | 8900 / 199340 (4.5%) | −236.4 | −233.9 | 2.34 |
| CEBPB SRX150632 | HeLa Uterus | 878 / 19934 (4.4%) | 22279 / 199340 (11.2%) | −235.8 | −233.3 | 0.39 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 908 / 19934 (4.6%) | 22710 / 199340 (11.4%) | −235.6 | −233.1 | 0.40 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 651 / 19934 (3.3%) | 18808 / 199340 (9.4%) | −235.4 | −232.9 | 0.35 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 747 / 19934 (3.7%) | 20255 / 199340 (10.2%) | −234.3 | −231.8 | 0.37 |
| PBX3 SRX190343 | SK-N-SH Neural | 799 / 19934 (4.0%) | 21042 / 199340 (10.6%) | −234.2 | −231.7 | 0.38 |
| JUND SRX190357 | SK-N-SH Neural | 456 / 19934 (2.3%) | 15575 / 199340 (7.8%) | −233.4 | −230.9 | 0.29 |
| FOXA1 SRX371481 | MCF-7 Breast | 402 / 19934 (2.0%) | 14649 / 199340 (7.3%) | −233.4 | −230.9 | 0.27 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1544 / 19934 (7.7%) | 31471 / 199340 (15.8%) | −232.9 | −230.5 | 0.49 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 277 / 19934 (1.4%) | 12374 / 199340 (6.2%) | −232.8 | −230.3 | 0.22 |
| JUNB SRX8488089 | SUM 229PE Breast | 349 / 19934 (1.8%) | 13693 / 199340 (6.9%) | −232.7 | −230.2 | 0.25 |
| JUN SRX7277180 | GM07492 Others | 276 / 19934 (1.4%) | 12318 / 199340 (6.2%) | −231.5 | −229.0 | 0.22 |
| SMARCA4 SRX5212371 | Mel270 Others | 522 / 19934 (2.6%) | 16605 / 199340 (8.3%) | −231.4 | −228.9 | 0.31 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 951 / 19934 (4.8%) | 23176 / 199340 (11.6%) | −231.1 | −228.7 | 0.41 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 447 / 19934 (2.2%) | 15346 / 199340 (7.7%) | −231.0 | −228.6 | 0.29 |
| FOXA1 SRX371483 | MCF-7 Breast | 438 / 19934 (2.2%) | 15152 / 199340 (7.6%) | −229.7 | −227.3 | 0.29 |
| 5-mC SRX882965 | LNCAP Prostate | 2749 / 19934 (13.8%) | 13681 / 199340 (6.9%) | −229.1 | −226.7 | 2.01 |
| ESR1 SRX7624156 | MCF-7 Breast | 633 / 19934 (3.2%) | 18306 / 199340 (9.2%) | −228.9 | −226.5 | 0.35 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 280 / 19934 (1.4%) | 12306 / 199340 (6.2%) | −228.5 | −226.1 | 0.23 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 662 / 19934 (3.3%) | 1130 / 199340 (0.6%) | −228.2 | −225.8 | 5.86 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2289 / 19934 (11.5%) | 10478 / 199340 (5.3%) | −227.8 | −225.4 | 2.18 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 319 / 19934 (1.6%) | 12997 / 199340 (6.5%) | −227.7 | −225.2 | 0.25 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 711 / 19934 (3.6%) | 19468 / 199340 (9.8%) | −227.6 | −225.2 | 0.37 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 659 / 19934 (3.3%) | 18653 / 199340 (9.4%) | −227.2 | −224.8 | 0.35 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 450 / 19934 (2.3%) | 15232 / 199340 (7.6%) | −225.8 | −223.4 | 0.30 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 876 / 19934 (4.4%) | 21865 / 199340 (11.0%) | −225.3 | −222.9 | 0.40 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 336 / 19934 (1.7%) | 13234 / 199340 (6.6%) | −225.3 | −222.9 | 0.25 |
| EP300 SRX2194265 | SUM 159PT Breast | 602 / 19934 (3.0%) | 17685 / 199340 (8.9%) | −225.2 | −222.8 | 0.34 |
| SREBF2 SRX5359048 | HCC70 Breast | 2031 / 19934 (10.2%) | 8804 / 199340 (4.4%) | −224.8 | −222.3 | 2.31 |
| FOXA1 SRX1161173 | MCF-7 Breast | 301 / 19934 (1.5%) | 12558 / 199340 (6.3%) | −224.0 | −221.6 | 0.24 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 485 / 19934 (2.4%) | 15736 / 199340 (7.9%) | −223.4 | −221.0 | 0.31 |
| WWTR1 SRX10119367 | MCF 10A Breast | 438 / 19934 (2.2%) | 14941 / 199340 (7.5%) | −223.1 | −220.8 | 0.29 |
| FOXA1 SRX1161175 | MCF-7 Breast | 279 / 19934 (1.4%) | 12111 / 199340 (6.1%) | −222.6 | −220.2 | 0.23 |
| ESR1 SRX371469 | MCF-7 Breast | 412 / 19934 (2.1%) | 14468 / 199340 (7.3%) | −222.2 | −219.9 | 0.28 |
| JUN SRX6582163 | BJ-5ta Epidermis | 466 / 19934 (2.3%) | 15379 / 199340 (7.7%) | −222.1 | −219.7 | 0.30 |
| TP53 SRX19538274 | U2OS Bone | 369 / 19934 (1.9%) | 236 / 199340 (0.1%) | −221.0 | −218.6 | 15.64 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 386 / 19934 (1.9%) | 276 / 199340 (0.1%) | −220.9 | −218.5 | 13.99 |
| JUN SRX6582165 | BJ-5ta Epidermis | 753 / 19934 (3.8%) | 19863 / 199340 (10.0%) | −220.7 | −218.3 | 0.38 |
| ESR1 SRX371479 | MCF-7 Breast | 359 / 19934 (1.8%) | 13484 / 199340 (6.8%) | −220.2 | −217.8 | 0.27 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 337 / 19934 (1.7%) | 13088 / 199340 (6.6%) | −220.0 | −217.6 | 0.26 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 352 / 19934 (1.8%) | 13352 / 199340 (6.7%) | −219.9 | −217.6 | 0.26 |
| ESR1 SRX20282961 | MCF-7 Breast | 514 / 19934 (2.6%) | 16093 / 199340 (8.1%) | −219.8 | −217.5 | 0.32 |
| EP300 SRX2194266 | SUM 159PT Breast | 681 / 19934 (3.4%) | 18730 / 199340 (9.4%) | −219.7 | −217.3 | 0.36 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 573 / 19934 (2.9%) | 17029 / 199340 (8.5%) | −219.4 | −217.1 | 0.34 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 608 / 19934 (3.1%) | 17580 / 199340 (8.8%) | −219.4 | −217.0 | 0.35 |
| MAU2 SRX15710550 | Fibroblasts Others | 650 / 19934 (3.3%) | 18234 / 199340 (9.1%) | −219.2 | −216.9 | 0.36 |
| FOXA1 SRX1161176 | MCF-7 Breast | 382 / 19934 (1.9%) | 13853 / 199340 (6.9%) | −219.1 | −216.8 | 0.28 |
| ESR1 SRX176860 | MCF-7 Breast | 671 / 19934 (3.4%) | 18538 / 199340 (9.3%) | −218.7 | −216.3 | 0.36 |
| JUNB SRX10119383 | MCF 10A Breast | 232 / 19934 (1.2%) | 11094 / 199340 (5.6%) | −218.4 | −216.1 | 0.21 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 768 / 19934 (3.9%) | 20005 / 199340 (10.0%) | −218.3 | −215.9 | 0.38 |
| RELA SRX5938177 | FaDu Others | 333 / 19934 (1.7%) | 12957 / 199340 (6.5%) | −218.1 | −215.8 | 0.26 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 581 / 19934 (2.9%) | 17094 / 199340 (8.6%) | −217.6 | −215.3 | 0.34 |
| TRP47 SRX4548329 | THP-1 Blood | 3049 / 19934 (15.3%) | 16216 / 199340 (8.1%) | −216.2 | −213.9 | 1.88 |
| NKX2-1 SRX2164786 | A549 Lung | 667 / 19934 (3.3%) | 18352 / 199340 (9.2%) | −215.1 | −212.8 | 0.36 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 714 / 19934 (3.6%) | 19050 / 199340 (9.6%) | −214.5 | −212.2 | 0.37 |
| TP53 SRX19538268 | U2OS Bone | 364 / 19934 (1.8%) | 244 / 199340 (0.1%) | −213.9 | −211.6 | 14.92 |
| ESR1 SRX371476 | MCF-7 Breast | 289 / 19934 (1.4%) | 12025 / 199340 (6.0%) | −213.6 | −211.3 | 0.24 |
| FOSL2 SRX190204 | A549 Lung | 373 / 19934 (1.9%) | 13517 / 199340 (6.8%) | −213.5 | −211.2 | 0.28 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 568 / 19934 (2.8%) | 16741 / 199340 (8.4%) | −213.2 | −210.9 | 0.34 |
| NR3C1 SRX2609664 | HASM2 Lung | 562 / 19934 (2.8%) | 16630 / 199340 (8.3%) | −212.8 | −210.5 | 0.34 |
| NR3C1 SRX2609659 | HASM2 Lung | 455 / 19934 (2.3%) | 14880 / 199340 (7.5%) | −212.5 | −210.2 | 0.31 |
| ESR1 SRX176861 | MCF-7 Breast | 683 / 19934 (3.4%) | 18502 / 199340 (9.3%) | −212.4 | −210.1 | 0.37 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 639 / 19934 (3.2%) | 1145 / 199340 (0.6%) | −211.8 | −209.5 | 5.58 |
| TP53 SRX19538276 | U2OS Bone | 367 / 19934 (1.8%) | 259 / 199340 (0.1%) | −211.1 | −208.8 | 14.17 |
| STAT3 SRX150479 | MCF 10A Breast | 356 / 19934 (1.8%) | 13147 / 199340 (6.6%) | −211.1 | −208.8 | 0.27 |
| JUND SRX699738 | HCASMC Cardiovascular | 552 / 19934 (2.8%) | 16404 / 199340 (8.2%) | −210.9 | −208.6 | 0.34 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 407 / 19934 (2.0%) | 14015 / 199340 (7.0%) | −210.8 | −208.5 | 0.29 |
| JUNB SRX10119384 | MCF 10A Breast | 208 / 19934 (1.0%) | 10395 / 199340 (5.2%) | −210.7 | −208.4 | 0.20 |
| TLE3 SRX4815191 | MCF-7 Breast | 397 / 19934 (2.0%) | 13816 / 199340 (6.9%) | −209.8 | −207.5 | 0.29 |
| STAT3 SRX150630 | MCF 10A Breast | 355 / 19934 (1.8%) | 13087 / 199340 (6.6%) | −209.7 | −207.4 | 0.27 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2266 / 19934 (11.4%) | 10745 / 199340 (5.4%) | −208.3 | −206.1 | 2.11 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 369 / 19934 (1.9%) | 13285 / 199340 (6.7%) | −208.2 | −205.9 | 0.28 |
| FOXA1 SRX371480 | MCF-7 Breast | 261 / 19934 (1.3%) | 11338 / 199340 (5.7%) | −208.1 | −205.8 | 0.23 |
| FOS SRX070879 | HUVEC Cardiovascular | 414 / 19934 (2.1%) | 14051 / 199340 (7.0%) | −208.1 | −205.8 | 0.29 |
| JUN SRX6582164 | BJ-5ta Epidermis | 497 / 19934 (2.5%) | 15407 / 199340 (7.7%) | −207.5 | −205.2 | 0.32 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 750 / 19934 (3.8%) | 19334 / 199340 (9.7%) | −207.2 | −205.0 | 0.39 |
| FOXA1 SRX3923514 | MCF-7 Breast | 412 / 19934 (2.1%) | 13971 / 199340 (7.0%) | −206.7 | −204.4 | 0.29 |
| FOS SRX150664 | HUVEC Cardiovascular | 534 / 19934 (2.7%) | 15947 / 199340 (8.0%) | −205.9 | −203.6 | 0.33 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1930 / 19934 (9.7%) | 8507 / 199340 (4.3%) | −205.8 | −203.6 | 2.27 |
| FOXA1 SRX1787653 | MCF-7 Breast | 320 / 19934 (1.6%) | 12336 / 199340 (6.2%) | −205.5 | −203.3 | 0.26 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 343 / 19934 (1.7%) | 12726 / 199340 (6.4%) | −205.0 | −202.7 | 0.27 |
| FOXA1 SRX11222442 | MCF-7 Breast | 252 / 19934 (1.3%) | 11068 / 199340 (5.6%) | −204.7 | −202.5 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 302 / 19934 (1.5%) | 11975 / 199340 (6.0%) | −204.2 | −201.9 | 0.25 |
| TEAD1 SRX3401272 | MCF-7 Breast | 292 / 19934 (1.5%) | 11791 / 199340 (5.9%) | −204.1 | −201.8 | 0.25 |
| JUN SRX2355072 | HAEC Cardiovascular | 534 / 19934 (2.7%) | 15866 / 199340 (8.0%) | −203.5 | −201.3 | 0.34 |
| ESR1 SRX20282960 | MCF-7 Breast | 490 / 19934 (2.5%) | 15149 / 199340 (7.6%) | −203.2 | −201.0 | 0.32 |
| EP300 SRX150579 | HeLa Uterus | 246 / 19934 (1.2%) | 10904 / 199340 (5.5%) | −202.9 | −200.7 | 0.23 |
| STAT3 SRX150536 | MCF 10A Breast | 454 / 19934 (2.3%) | 14536 / 199340 (7.3%) | −202.5 | −200.3 | 0.31 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2122 / 19934 (10.6%) | 9881 / 199340 (5.0%) | −202.4 | −200.2 | 2.15 |
| FOXL2 SRX6957431 | KGN Gonad | 974 / 19934 (4.9%) | 22409 / 199340 (11.2%) | −202.2 | −200.0 | 0.43 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 298 / 19934 (1.5%) | 11838 / 199340 (5.9%) | −202.2 | −200.0 | 0.25 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 637 / 19934 (3.2%) | 17435 / 199340 (8.7%) | −202.2 | −199.9 | 0.37 |
| ESR1 SRX20282939 | MCF-7 Breast | 488 / 19934 (2.4%) | 15077 / 199340 (7.6%) | −202.1 | −199.9 | 0.32 |
| NR3C1 SRX2609662 | HASM2 Lung | 492 / 19934 (2.5%) | 15119 / 199340 (7.6%) | −201.4 | −199.2 | 0.33 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 405 / 19934 (2.0%) | 13672 / 199340 (6.9%) | −201.2 | −198.9 | 0.30 |
| NR3C1 SRX2609665 | HASM2 Lung | 453 / 19934 (2.3%) | 14474 / 199340 (7.3%) | −201.1 | −198.9 | 0.31 |
| SMARCA4 SRX8566546 | 786-O Kidney | 1477 / 19934 (7.4%) | 29236 / 199340 (14.7%) | −200.8 | −198.6 | 0.51 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 700 / 19934 (3.5%) | 18334 / 199340 (9.2%) | −200.5 | −198.3 | 0.38 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 542 / 19934 (2.7%) | 15882 / 199340 (8.0%) | −200.3 | −198.1 | 0.34 |
| FOS SRX3322636 | MCF-7 Breast | 239 / 19934 (1.2%) | 10694 / 199340 (5.4%) | −200.3 | −198.1 | 0.22 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 620 / 19934 (3.1%) | 1146 / 199340 (0.6%) | −200.2 | −198.0 | 5.41 |
| GATA3 SRX176864 | MCF-7 Breast | 298 / 19934 (1.5%) | 11775 / 199340 (5.9%) | −200.1 | −197.9 | 0.25 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 264 / 19934 (1.3%) | 11143 / 199340 (5.6%) | −199.7 | −197.5 | 0.24 |
| SMARCA4 SRX15419260 | 786-O Kidney | 1479 / 19934 (7.4%) | 29212 / 199340 (14.7%) | −199.7 | −197.4 | 0.51 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1838 / 19934 (9.2%) | 8021 / 199340 (4.0%) | −199.5 | −197.3 | 2.29 |
| NR3C1 SRX2609661 | HASM2 Lung | 453 / 19934 (2.3%) | 14417 / 199340 (7.2%) | −199.5 | −197.3 | 0.31 |
| ESR1 SRX371471 | ZR-75-1 Breast | 467 / 19934 (2.3%) | 14640 / 199340 (7.3%) | −199.2 | −197.0 | 0.32 |
| RAC1 SRX10365541 | MCF-7 Breast | 207 / 19934 (1.0%) | 10020 / 199340 (5.0%) | −198.4 | −196.2 | 0.21 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 289 / 19934 (1.4%) | 11559 / 199340 (5.8%) | −198.4 | −196.2 | 0.25 |
| BMI1 SRX7196721 | SF8628 Neural | 2002 / 19934 (10.0%) | 9147 / 199340 (4.6%) | −198.4 | −196.2 | 2.19 |
| FOXA1 SRX11222437 | MCF-7 Breast | 289 / 19934 (1.4%) | 11563 / 199340 (5.8%) | −198.4 | −196.2 | 0.25 |
| FOXA1 SRX1161174 | MCF-7 Breast | 439 / 19934 (2.2%) | 14141 / 199340 (7.1%) | −198.2 | −196.0 | 0.31 |
| YAP1 SRX1038945 | IMR-90 Lung | 293 / 19934 (1.5%) | 11602 / 199340 (5.8%) | −197.4 | −195.2 | 0.25 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 242 / 19934 (1.2%) | 10643 / 199340 (5.3%) | −196.7 | −194.5 | 0.23 |
| MITF SRX1555436 | 501A Epidermis | 2272 / 19934 (11.4%) | 11061 / 199340 (5.5%) | −196.6 | −194.5 | 2.05 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 390 / 19934 (2.0%) | 13255 / 199340 (6.6%) | −196.2 | −194.0 | 0.29 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 418 / 19934 (2.1%) | 13721 / 199340 (6.9%) | −196.0 | −193.8 | 0.30 |
| ARID1A SRX5679788 | 12Z Others | 145 / 19934 (0.7%) | 8667 / 199340 (4.3%) | −195.1 | −192.9 | 0.17 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 628 / 19934 (3.2%) | 17043 / 199340 (8.5%) | −195.0 | −192.8 | 0.37 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 286 / 19934 (1.4%) | 11393 / 199340 (5.7%) | −194.7 | −192.6 | 0.25 |
| ARID1A SRX5089376 | MCF-7 Breast | 362 / 19934 (1.8%) | 12719 / 199340 (6.4%) | −194.4 | −192.2 | 0.28 |
| NR3C1 SRX2609666 | HASM2 Lung | 399 / 19934 (2.0%) | 13348 / 199340 (6.7%) | −194.3 | −192.2 | 0.30 |
| RNF2 SRX18954719 | SCC-25 Others | 570 / 19934 (2.9%) | 16117 / 199340 (8.1%) | −194.3 | −192.1 | 0.35 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 455 / 19934 (2.3%) | 14268 / 199340 (7.2%) | −194.1 | −191.9 | 0.32 |
| EP300 SRX10976215 | A549 Lung | 374 / 19934 (1.9%) | 12903 / 199340 (6.5%) | −193.7 | −191.5 | 0.29 |
| WWTR1 SRX10119378 | MCF 10A Breast | 451 / 19934 (2.3%) | 14186 / 199340 (7.1%) | −193.6 | −191.4 | 0.32 |
| ESR1 SRX371470 | ZR-75-1 Breast | 400 / 19934 (2.0%) | 13332 / 199340 (6.7%) | −193.3 | −191.1 | 0.30 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2079 / 19934 (10.4%) | 9791 / 199340 (4.9%) | −193.1 | −191.0 | 2.12 |
| TP53 SRX19538275 | U2OS Bone | 335 / 19934 (1.7%) | 237 / 199340 (0.1%) | −192.6 | −190.4 | 14.13 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2072 / 19934 (10.4%) | 9760 / 199340 (4.9%) | −192.2 | −190.1 | 2.12 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 443 / 19934 (2.2%) | 13988 / 199340 (7.0%) | −191.5 | −189.3 | 0.32 |
| TP53 SRX19538267 | U2OS Bone | 323 / 19934 (1.6%) | 212 / 199340 (0.1%) | −191.5 | −189.3 | 15.24 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 385 / 19934 (1.9%) | 13017 / 199340 (6.5%) | −191.4 | −189.3 | 0.30 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 359 / 19934 (1.8%) | 12567 / 199340 (6.3%) | −191.2 | −189.0 | 0.29 |
| Epitope tags SRX10549776 | K-562 Blood | 1521 / 19934 (7.6%) | 6129 / 199340 (3.1%) | −190.8 | −188.7 | 2.48 |
| MECOM SRX23677896 | HNT-34 Blood | 2440 / 19934 (12.2%) | 12405 / 199340 (6.2%) | −190.8 | −188.6 | 1.97 |
| FOXA1 SRX3931043 | MCF-7 Breast | 440 / 19934 (2.2%) | 13909 / 199340 (7.0%) | −190.7 | −188.6 | 0.32 |
| GATA3 SRX5057632 | MCF-7 Breast | 277 / 19934 (1.4%) | 11096 / 199340 (5.6%) | −190.4 | −188.2 | 0.25 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2102 / 19934 (10.5%) | 10017 / 199340 (5.0%) | −190.2 | −188.1 | 2.10 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 288 / 19934 (1.4%) | 11286 / 199340 (5.7%) | −190.2 | −188.0 | 0.26 |
| FOXA1 SRX100454 | T-47D Breast | 576 / 19934 (2.9%) | 16054 / 199340 (8.1%) | −189.9 | −187.7 | 0.36 |
| STAT3 SRX2020842 | HCC70 Breast | 770 / 19934 (3.9%) | 18984 / 199340 (9.5%) | −189.7 | −187.6 | 0.41 |
| TP53 SRX19538280 | Osteoblasts Bone | 351 / 19934 (1.8%) | 286 / 199340 (0.1%) | −189.5 | −187.4 | 12.27 |
| JUND SRX150408 | HeLa Uterus | 360 / 19934 (1.8%) | 12532 / 199340 (6.3%) | −189.5 | −187.4 | 0.29 |
| ESR1 SRX1531791 | MCF-7 Breast | 431 / 19934 (2.2%) | 13722 / 199340 (6.9%) | −189.5 | −187.3 | 0.31 |
| MECOM SRX23677897 | HNT-34 Blood | 2352 / 19934 (11.8%) | 11807 / 199340 (5.9%) | −189.4 | −187.2 | 1.99 |
| ARID1A SRX5679787 | 12Z Others | 139 / 19934 (0.7%) | 8373 / 199340 (4.2%) | −189.2 | −187.0 | 0.17 |
| RUNX1 SRX2014504 | Jurkat Blood | 2778 / 19934 (13.9%) | 14955 / 199340 (7.5%) | −188.7 | −186.6 | 1.86 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 254 / 19934 (1.3%) | 10622 / 199340 (5.3%) | −188.7 | −186.5 | 0.24 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 306 / 19934 (1.5%) | 11559 / 199340 (5.8%) | −188.6 | −186.4 | 0.26 |
| ESR1 SRX371467 | MCF-7 Breast | 473 / 19934 (2.4%) | 14365 / 199340 (7.2%) | −188.3 | −186.2 | 0.33 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 474 / 19934 (2.4%) | 14382 / 199340 (7.2%) | −188.3 | −186.2 | 0.33 |
| IRF3 SRX11453858 | Hep G2 Liver | 275 / 19934 (1.4%) | 120 / 199340 (0.1%) | −188.0 | −185.9 | 22.92 |
| ESR1 SRX20282972 | MCF-7 Breast | 501 / 19934 (2.5%) | 14805 / 199340 (7.4%) | −187.9 | −185.8 | 0.34 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 649 / 19934 (3.3%) | 17104 / 199340 (8.6%) | −187.8 | −185.7 | 0.38 |
| ESR1 SRX4367192 | MCF-7 Breast | 901 / 19934 (4.5%) | 20808 / 199340 (10.4%) | −187.8 | −185.6 | 0.43 |
| FOXA1 SRX1787652 | MCF-7 Breast | 250 / 19934 (1.3%) | 10517 / 199340 (5.3%) | −187.6 | −185.5 | 0.24 |
| TP53 SRX19538273 | U2OS Bone | 319 / 19934 (1.6%) | 214 / 199340 (0.1%) | −187.4 | −185.3 | 14.91 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 492 / 19934 (2.5%) | 14636 / 199340 (7.3%) | −187.1 | −185.0 | 0.34 |
| ESR1 SRX20282954 | MCF-7 Breast | 493 / 19934 (2.5%) | 14630 / 199340 (7.3%) | −186.6 | −184.5 | 0.34 |
| DAXX SRX1021630 | PC-3 Prostate | 429 / 19934 (2.2%) | 13578 / 199340 (6.8%) | −186.1 | −184.0 | 0.32 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2176 / 19934 (10.9%) | 10631 / 199340 (5.3%) | −186.1 | −184.0 | 2.05 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 616 / 19934 (3.1%) | 16540 / 199340 (8.3%) | −186.1 | −184.0 | 0.37 |
| FOXA1 SRX3931055 | MCF-7 Breast | 367 / 19934 (1.8%) | 12532 / 199340 (6.3%) | −185.9 | −183.8 | 0.29 |
| CEBPB SRX150598 | IMR-90 Lung | 900 / 19934 (4.5%) | 20703 / 199340 (10.4%) | −185.5 | −183.4 | 0.43 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 329 / 19934 (1.7%) | 11862 / 199340 (6.0%) | −185.4 | −183.3 | 0.28 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 405 / 19934 (2.0%) | 13136 / 199340 (6.6%) | −184.8 | −182.7 | 0.31 |
| RAC1 SRX10365543 | MCF-7 Breast | 227 / 19934 (1.1%) | 9999 / 199340 (5.0%) | −184.7 | −182.7 | 0.23 |
| MECOM SRX23677885 | HNT-34 Blood | 2009 / 19934 (10.1%) | 9496 / 199340 (4.8%) | −184.6 | −182.5 | 2.12 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1978 / 19934 (9.9%) | 9301 / 199340 (4.7%) | −183.8 | −181.7 | 2.13 |
| ESR1 SRX371468 | MCF-7 Breast | 288 / 19934 (1.4%) | 11089 / 199340 (5.6%) | −183.8 | −181.7 | 0.26 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 405 / 19934 (2.0%) | 13086 / 199340 (6.6%) | −183.3 | −181.2 | 0.31 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 393 / 19934 (2.0%) | 12871 / 199340 (6.5%) | −182.8 | −180.8 | 0.31 |
| FOXA1 SRX3923516 | MCF-7 Breast | 309 / 19934 (1.6%) | 11428 / 199340 (5.7%) | −182.7 | −180.6 | 0.27 |
| NR3C1 SRX10976921 | A549 Lung | 299 / 19934 (1.5%) | 11246 / 199340 (5.6%) | −182.6 | −180.5 | 0.27 |
| EP300 SRX10976625 | A549 Lung | 238 / 19934 (1.2%) | 10108 / 199340 (5.1%) | −181.6 | −179.5 | 0.24 |
| ESR1 SRX194569 | MCF-7 Breast | 486 / 19934 (2.4%) | 14341 / 199340 (7.2%) | −181.4 | −179.4 | 0.34 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 420 / 19934 (2.1%) | 13265 / 199340 (6.7%) | −181.3 | −179.2 | 0.32 |
| FOS SRX3322637 | MCF-7 Breast | 212 / 19934 (1.1%) | 9602 / 199340 (4.8%) | −181.0 | −179.0 | 0.22 |
| FOXA1 SRX3931054 | MCF-7 Breast | 419 / 19934 (2.1%) | 13241 / 199340 (6.6%) | −181.0 | −178.9 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 208 / 19934 (1.0%) | 9510 / 199340 (4.8%) | −180.5 | −178.4 | 0.22 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 582 / 19934 (2.9%) | 15810 / 199340 (7.9%) | −180.4 | −178.4 | 0.37 |
| ARID1A SRX5089379 | MCF-7 Breast | 440 / 19934 (2.2%) | 13564 / 199340 (6.8%) | −180.4 | −178.3 | 0.32 |
| FOXA1 SRX1447317 | MCF-7 Breast | 280 / 19934 (1.4%) | 10831 / 199340 (5.4%) | −180.1 | −178.1 | 0.26 |
| TP53 SRX19538281 | Osteoblasts Bone | 376 / 19934 (1.9%) | 389 / 199340 (0.2%) | −180.1 | −178.0 | 9.67 |
| SP1 SRX190269 | A549 Lung | 653 / 19934 (3.3%) | 16870 / 199340 (8.5%) | −179.8 | −177.7 | 0.39 |
| FOXA1 SRX190181 | A549 Lung | 311 / 19934 (1.6%) | 11359 / 199340 (5.7%) | −179.4 | −177.3 | 0.27 |
| WWTR1 SRX10119368 | MCF 10A Breast | 302 / 19934 (1.5%) | 11201 / 199340 (5.6%) | −179.4 | −177.3 | 0.27 |
| CEBPB SRX2194249 | SUM 159PT Breast | 432 / 19934 (2.2%) | 13389 / 199340 (6.7%) | −179.1 | −177.1 | 0.32 |
| AR SRX1067067 | LHSAR Prostate | 768 / 19934 (3.9%) | 18547 / 199340 (9.3%) | −179.0 | −176.9 | 0.41 |
| ESR1 SRX194572 | MCF-7 Breast | 295 / 19934 (1.5%) | 11051 / 199340 (5.5%) | −178.6 | −176.5 | 0.27 |
| FOXA1 SRX1787655 | MCF-7 Breast | 212 / 19934 (1.1%) | 9525 / 199340 (4.8%) | −178.5 | −176.4 | 0.22 |
| MECOM SRX23677884 | HNT-34 Blood | 1964 / 19934 (9.9%) | 9324 / 199340 (4.7%) | −178.4 | −176.4 | 2.11 |
| FOXA1 SRX3923517 | MCF-7 Breast | 314 / 19934 (1.6%) | 11355 / 199340 (5.7%) | −177.7 | −175.6 | 0.28 |
| ESR1 SRX2943591 | MCF-7 Breast | 310 / 19934 (1.6%) | 11282 / 199340 (5.7%) | −177.6 | −175.5 | 0.27 |
| FOXA1 SRX1787651 | MCF-7 Breast | 245 / 19934 (1.2%) | 10105 / 199340 (5.1%) | −177.2 | −175.1 | 0.24 |
| NR3C1 SRX10977372 | A549 Lung | 244 / 19934 (1.2%) | 10086 / 199340 (5.1%) | −177.1 | −175.0 | 0.24 |
| TLE3 SRX4815192 | MCF-7 Breast | 409 / 19934 (2.1%) | 12935 / 199340 (6.5%) | −176.9 | −174.8 | 0.32 |
| FOXA1 SRX11222438 | MCF-7 Breast | 231 / 19934 (1.2%) | 9835 / 199340 (4.9%) | −176.9 | −174.8 | 0.23 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 324 / 19934 (1.6%) | 11496 / 199340 (5.8%) | −176.7 | −174.6 | 0.28 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 358 / 19934 (1.8%) | 12071 / 199340 (6.1%) | −176.5 | −174.4 | 0.30 |
| ESR1 SRX10365536 | MCF-7 Breast | 239 / 19934 (1.2%) | 9971 / 199340 (5.0%) | −176.4 | −174.4 | 0.24 |
| CEBPB SRX2194250 | SUM 159PT Breast | 550 / 19934 (2.8%) | 15171 / 199340 (7.6%) | −176.4 | −174.4 | 0.36 |
| CEBPB SRX190345 | MCF-7 Breast | 342 / 19934 (1.7%) | 11793 / 199340 (5.9%) | −176.3 | −174.2 | 0.29 |
| JUNB SRX2443774 | A549 Lung | 173 / 19934 (0.9%) | 8703 / 199340 (4.4%) | −176.3 | −174.2 | 0.20 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 581 / 19934 (2.9%) | 15629 / 199340 (7.8%) | −175.8 | −173.8 | 0.37 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 507 / 19934 (2.5%) | 14470 / 199340 (7.3%) | −175.5 | −173.5 | 0.35 |
| TEAD1 SRX716558 | SF268 Neural | 211 / 19934 (1.1%) | 9411 / 199340 (4.7%) | −175.2 | −173.2 | 0.22 |
| TLE3 SRX4815194 | SUM 149PT Breast | 335 / 19934 (1.7%) | 11635 / 199340 (5.8%) | −175.1 | −173.1 | 0.29 |
| ESR1 SRX371477 | MCF-7 Breast | 221 / 19934 (1.1%) | 9598 / 199340 (4.8%) | −175.1 | −173.1 | 0.23 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 204 / 19934 (1.0%) | 9273 / 199340 (4.7%) | −175.1 | −173.0 | 0.22 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 672 / 19934 (3.4%) | 16978 / 199340 (8.5%) | −175.0 | −173.0 | 0.40 |
| BRD4 SRX327751 | U-87 MG Neural | 1276 / 19934 (6.4%) | 25444 / 199340 (12.8%) | −174.9 | −172.9 | 0.50 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 324 / 19934 (1.6%) | 11430 / 199340 (5.7%) | −174.7 | −172.6 | 0.28 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 424 / 19934 (2.1%) | 13103 / 199340 (6.6%) | −174.6 | −172.5 | 0.32 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 427 / 19934 (2.1%) | 13153 / 199340 (6.6%) | −174.5 | −172.5 | 0.32 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 266 / 19934 (1.3%) | 10388 / 199340 (5.2%) | −174.0 | −172.0 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 225 / 19934 (1.1%) | 9634 / 199340 (4.8%) | −173.9 | −171.9 | 0.23 |
| NR3C1 SRX17639412 | A549 Lung | 511 / 19934 (2.6%) | 14464 / 199340 (7.3%) | −173.6 | −171.6 | 0.35 |
| ESR1 SRX20282973 | MCF-7 Breast | 564 / 19934 (2.8%) | 15278 / 199340 (7.7%) | −173.3 | −171.3 | 0.37 |
| FOXA2 SRX3230382 | Hep G2 Liver | 637 / 19934 (3.2%) | 16376 / 199340 (8.2%) | −172.9 | −170.9 | 0.39 |
| AR SRX10820653 | LNCAP Prostate | 319 / 19934 (1.6%) | 258 / 199340 (0.1%) | −172.9 | −170.9 | 12.36 |
| FOXA1 SRX15430999 | T-47D Breast | 514 / 19934 (2.6%) | 14480 / 199340 (7.3%) | −172.7 | −170.7 | 0.35 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 543 / 19934 (2.7%) | 14931 / 199340 (7.5%) | −172.6 | −170.6 | 0.36 |
| FOXA1 SRX3923518 | MCF-7 Breast | 311 / 19934 (1.6%) | 11136 / 199340 (5.6%) | −172.5 | −170.5 | 0.28 |
| BRD4 SRX327752 | U-87 MG Neural | 822 / 19934 (4.1%) | 19071 / 199340 (9.6%) | −172.4 | −170.4 | 0.43 |
| AR SRX1067066 | LHSAR Prostate | 969 / 19934 (4.9%) | 21148 / 199340 (10.6%) | −172.3 | −170.3 | 0.46 |
| FOSL1 SRX17608312 | T24 Others | 155 / 19934 (0.8%) | 8222 / 199340 (4.1%) | −172.2 | −170.2 | 0.19 |
| JUN SRX699737 | HCASMC Cardiovascular | 286 / 19934 (1.4%) | 10678 / 199340 (5.4%) | −171.9 | −169.9 | 0.27 |
| NR3C1 SRX10977357 | A549 Lung | 275 / 19934 (1.4%) | 10484 / 199340 (5.3%) | −171.9 | −169.9 | 0.26 |
| SMAD3 SRX366168 | NCI-H441 Lung | 390 / 19934 (2.0%) | 12455 / 199340 (6.2%) | −171.8 | −169.8 | 0.31 |
| GATA3 SRX5457550 | MCF-7 Breast | 521 / 19934 (2.6%) | 14555 / 199340 (7.3%) | −171.8 | −169.8 | 0.36 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 572 / 19934 (2.9%) | 1149 / 199340 (0.6%) | −171.7 | −169.7 | 4.98 |
| Epitope tags SRX2745846 | MCF 10A Breast | 291 / 19934 (1.5%) | 10759 / 199340 (5.4%) | −171.6 | −169.7 | 0.27 |
| SMARCA4 SRX5982340 | A549 Lung | 167 / 19934 (0.8%) | 8446 / 199340 (4.2%) | −171.5 | −169.5 | 0.20 |
| EP300 SRX176885 | MCF-7 Breast | 231 / 19934 (1.2%) | 9668 / 199340 (4.9%) | −171.3 | −169.3 | 0.24 |
| JUNB SRX10119385 | MCF 10A Breast | 190 / 19934 (1.0%) | 8884 / 199340 (4.5%) | −171.1 | −169.1 | 0.21 |
| RNF2 SRX18954704 | FaDu Others | 1094 / 19934 (5.5%) | 22823 / 199340 (11.4%) | −171.1 | −169.1 | 0.48 |
| FOXA1 SRX100506 | Hep G2 Liver | 625 / 19934 (3.1%) | 16111 / 199340 (8.1%) | −170.7 | −168.7 | 0.39 |
| SP1 SRX190358 | HCT 116 Digestive tract | 715 / 19934 (3.6%) | 17449 / 199340 (8.8%) | −170.6 | −168.6 | 0.41 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 274 / 19934 (1.4%) | 10409 / 199340 (5.2%) | −170.0 | −168.1 | 0.26 |
| FOXA1 SRX028635 | MCF-7 Breast | 223 / 19934 (1.1%) | 9473 / 199340 (4.8%) | −169.8 | −167.9 | 0.24 |
| MYC SRX150570 | MCF 10A Breast | 299 / 19934 (1.5%) | 10842 / 199340 (5.4%) | −169.8 | −167.8 | 0.28 |
| ARID1A SRX5089385 | MCF-7 Breast | 338 / 19934 (1.7%) | 11506 / 199340 (5.8%) | −169.6 | −167.6 | 0.29 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 625 / 19934 (3.1%) | 16071 / 199340 (8.1%) | −169.5 | −167.5 | 0.39 |
| NFIC SRX190336 | SK-N-SH Neural | 648 / 19934 (3.3%) | 16414 / 199340 (8.2%) | −169.5 | −167.5 | 0.39 |
| GATA3 SRX6712581 | MCF-7 Breast | 385 / 19934 (1.9%) | 12289 / 199340 (6.2%) | −169.4 | −167.5 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 302 / 19934 (1.5%) | 10853 / 199340 (5.4%) | −168.5 | −166.6 | 0.28 |
| JUN SRX2355073 | HAEC Cardiovascular | 581 / 19934 (2.9%) | 15352 / 199340 (7.7%) | −168.2 | −166.2 | 0.38 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 597 / 19934 (3.0%) | 15594 / 199340 (7.8%) | −168.1 | −166.2 | 0.38 |
| NR3C1 SRX10977373 | A549 Lung | 242 / 19934 (1.2%) | 9766 / 199340 (4.9%) | −168.0 | −166.1 | 0.25 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 303 / 19934 (1.5%) | 10843 / 199340 (5.4%) | −167.6 | −165.6 | 0.28 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 597 / 19934 (3.0%) | 15565 / 199340 (7.8%) | −167.4 | −165.4 | 0.38 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 649 / 19934 (3.3%) | 16333 / 199340 (8.2%) | −167.0 | −165.0 | 0.40 |
| AGO2 SRX6783957 | Hep G2 Liver | 1335 / 19934 (6.7%) | 5375 / 199340 (2.7%) | −166.9 | −164.9 | 2.48 |
| FOSL2 SRX10475404 | A549 Lung | 224 / 19934 (1.1%) | 9397 / 199340 (4.7%) | −166.8 | −164.8 | 0.24 |
| ESR1 SRX20282940 | MCF-7 Breast | 524 / 19934 (2.6%) | 14422 / 199340 (7.2%) | −166.8 | −164.8 | 0.36 |
| ESR1 SRX10365535 | MCF-7 Breast | 390 / 19934 (2.0%) | 12270 / 199340 (6.2%) | −166.4 | −164.5 | 0.32 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 475 / 19934 (2.4%) | 794 / 199340 (0.4%) | −166.2 | −164.3 | 5.98 |
| ARID5B SRX3230377 | Hep G2 Liver | 1174 / 19934 (5.9%) | 23694 / 199340 (11.9%) | −166.1 | −164.1 | 0.50 |
| FOXA1 SRX3931033 | MCF-7 Breast | 295 / 19934 (1.5%) | 10647 / 199340 (5.3%) | −166.0 | −164.0 | 0.28 |
| FOXA2 SRX100448 | Hep G2 Liver | 531 / 19934 (2.7%) | 14496 / 199340 (7.3%) | −165.7 | −163.8 | 0.37 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 374 / 19934 (1.9%) | 11977 / 199340 (6.0%) | −165.5 | −163.5 | 0.31 |
| FOXA1 SRX3923519 | MCF-7 Breast | 285 / 19934 (1.4%) | 10454 / 199340 (5.2%) | −165.4 | −163.5 | 0.27 |
| CEBPA SRX2630241 | Hep G2 Liver | 582 / 19934 (2.9%) | 15263 / 199340 (7.7%) | −165.4 | −163.4 | 0.38 |
| FOXA1 SRX190282 | A549 Lung | 326 / 19934 (1.6%) | 11162 / 199340 (5.6%) | −165.3 | −163.4 | 0.29 |
| RORC SRX5359052 | HCC70 Breast | 1449 / 19934 (7.3%) | 6133 / 199340 (3.1%) | −165.3 | −163.4 | 2.36 |
| EP300 SRX100540 | SK-N-SH Neural | 680 / 19934 (3.4%) | 16731 / 199340 (8.4%) | −165.3 | −163.3 | 0.41 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1325 / 19934 (6.6%) | 25673 / 199340 (12.9%) | −165.3 | −163.3 | 0.52 |
| ESR1 SRX20282955 | MCF-7 Breast | 509 / 19934 (2.6%) | 14136 / 199340 (7.1%) | −165.3 | −163.3 | 0.36 |
| KAT6A SRX20971022 | Fibroblasts Others | 244 / 19934 (1.2%) | 111 / 199340 (0.1%) | −164.8 | −162.8 | 21.98 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 309 / 19934 (1.6%) | 10846 / 199340 (5.4%) | −164.5 | −162.6 | 0.28 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 227 / 19934 (1.1%) | 9379 / 199340 (4.7%) | −164.3 | −162.4 | 0.24 |
| YAP1 SRX10119363 | MCF 10A Breast | 187 / 19934 (0.9%) | 8617 / 199340 (4.3%) | −164.1 | −162.1 | 0.22 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 385 / 19934 (1.9%) | 12110 / 199340 (6.1%) | −164.0 | −162.1 | 0.32 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 200 / 19934 (1.0%) | 8862 / 199340 (4.4%) | −163.9 | −162.0 | 0.23 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2313 / 19934 (11.6%) | 12191 / 199340 (6.1%) | −163.9 | −161.9 | 1.90 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 387 / 19934 (1.9%) | 12137 / 199340 (6.1%) | −163.8 | −161.9 | 0.32 |
| NR2F2 SRX190293 | MCF-7 Breast | 509 / 19934 (2.6%) | 14058 / 199340 (7.1%) | −163.1 | −161.2 | 0.36 |
| JUN SRX883585 | MDA-MB-231 Breast | 547 / 19934 (2.7%) | 14641 / 199340 (7.3%) | −163.0 | −161.0 | 0.37 |
| TP53 SRX19538269 | U2OS Bone | 401 / 19934 (2.0%) | 545 / 199340 (0.3%) | −162.9 | −160.9 | 7.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 287 / 19934 (1.4%) | 10381 / 199340 (5.2%) | −162.0 | −160.1 | 0.28 |
| STAT3 SRX8520800 | SUM 159PT Breast | 282 / 19934 (1.4%) | 10292 / 199340 (5.2%) | −162.0 | −160.0 | 0.27 |
| SMARCA4 SRX5982364 | A549 Lung | 134 / 19934 (0.7%) | 7482 / 199340 (3.8%) | −161.4 | −159.5 | 0.18 |
| ESR1 SRX330067 | MCF-7 Breast | 438 / 19934 (2.2%) | 12873 / 199340 (6.5%) | −161.3 | −159.4 | 0.34 |
| FOXA1 SRX3923515 | MCF-7 Breast | 264 / 19934 (1.3%) | 9954 / 199340 (5.0%) | −161.3 | −159.3 | 0.27 |
| ESR1 SRX2881002 | MCF-7 Breast | 462 / 19934 (2.3%) | 13254 / 199340 (6.6%) | −161.1 | −159.2 | 0.35 |
| ARID1A SRX5089382 | MCF-7 Breast | 335 / 19934 (1.7%) | 11167 / 199340 (5.6%) | −160.8 | −158.9 | 0.30 |
| FOXA1 SRX3931056 | MCF-7 Breast | 280 / 19934 (1.4%) | 10219 / 199340 (5.1%) | −160.8 | −158.8 | 0.27 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 342 / 19934 (1.7%) | 11282 / 199340 (5.7%) | −160.7 | −158.8 | 0.30 |
| ATF3 SRX1384025 | HCT 116 Digestive tract | 281 / 19934 (1.4%) | 10235 / 199340 (5.1%) | −160.7 | −158.8 | 0.27 |
| PGR SRX1012655 | MCF-7 Breast | 310 / 19934 (1.6%) | 10734 / 199340 (5.4%) | −160.6 | −158.7 | 0.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 1309 / 19934 (6.6%) | 5325 / 199340 (2.7%) | −160.5 | −158.6 | 2.46 |
| FOXA1 SRX1961157 | T-47D Breast | 526 / 19934 (2.6%) | 14222 / 199340 (7.1%) | −160.3 | −158.4 | 0.37 |
| FOSL2 SRX8616829 | A549 Lung | 486 / 19934 (2.4%) | 13602 / 199340 (6.8%) | −160.3 | −158.4 | 0.36 |
| PRMT1 SRX3642947 | Keratinocytes Epidermis | 269 / 19934 (1.3%) | 10011 / 199340 (5.0%) | −160.3 | −158.4 | 0.27 |
| NR3C1 SRX1672128 | BEAS-2B Lung | 337 / 19934 (1.7%) | 11175 / 199340 (5.6%) | −160.0 | −158.1 | 0.30 |
| MethylCap SRX014767 | NB-4 Blood | 1917 / 19934 (9.6%) | 9434 / 199340 (4.7%) | −159.8 | −157.9 | 2.03 |
| HOXC5 SRX2731653 | PC-3 Prostate | 374 / 19934 (1.9%) | 11780 / 199340 (5.9%) | −159.7 | −157.8 | 0.32 |
| RNF2 SRX18954706 | SCC-25 Others | 586 / 19934 (2.9%) | 15112 / 199340 (7.6%) | −159.6 | −157.7 | 0.39 |
| EP300 SRX190219 | SK-N-SH Neural | 470 / 19934 (2.4%) | 13318 / 199340 (6.7%) | −159.4 | −157.5 | 0.35 |
| FOXA1 SRX5203303 | MCF-7 Breast | 157 / 19934 (0.8%) | 7887 / 199340 (4.0%) | −159.3 | −157.3 | 0.20 |
| NR3C1 SRX18884271 | A549 Lung | 251 / 19934 (1.3%) | 9654 / 199340 (4.8%) | −159.2 | −157.3 | 0.26 |
| RORC SRX5359053 | HCC70 Breast | 1387 / 19934 (7.0%) | 5848 / 199340 (2.9%) | −159.2 | −157.3 | 2.37 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1840 / 19934 (9.2%) | 8909 / 199340 (4.5%) | −159.1 | −157.2 | 2.07 |
| ARID1A SRX5089391 | MCF-7 Breast | 264 / 19934 (1.3%) | 9879 / 199340 (5.0%) | −159.0 | −157.0 | 0.27 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 454 / 19934 (2.3%) | 13044 / 199340 (6.5%) | −158.9 | −157.0 | 0.35 |
| FOXA1 SRX1161203 | T-47D Breast | 347 / 19934 (1.7%) | 11306 / 199340 (5.7%) | −158.9 | −157.0 | 0.31 |
| CEBPB SRX3584202 | Epididymis Gonad | 445 / 19934 (2.2%) | 12896 / 199340 (6.5%) | −158.7 | −156.8 | 0.35 |
| CEBPB SRX2194247 | SUM 159PT Breast | 404 / 19934 (2.0%) | 12237 / 199340 (6.1%) | −158.6 | −156.7 | 0.33 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 685 / 19934 (3.4%) | 16542 / 199340 (8.3%) | −158.5 | −156.6 | 0.41 |
| ESR1 SRX2881000 | MCF-7 Breast | 431 / 19934 (2.2%) | 12667 / 199340 (6.4%) | −158.5 | −156.6 | 0.34 |
| FOXA1 SRX13814018 | 5637 Others | 299 / 19934 (1.5%) | 10474 / 199340 (5.3%) | −158.3 | −156.4 | 0.29 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 312 / 19934 (1.6%) | 10695 / 199340 (5.4%) | −158.3 | −156.4 | 0.29 |
| BRD1 SRX286203 | RKO Digestive tract | 1232 / 19934 (6.2%) | 4880 / 199340 (2.4%) | −158.3 | −156.4 | 2.52 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1177 / 19934 (5.9%) | 4538 / 199340 (2.3%) | −158.2 | −156.3 | 2.59 |
| ESR1 SRX330069 | MCF-7 Breast | 300 / 19934 (1.5%) | 10480 / 199340 (5.3%) | −158.0 | −156.1 | 0.29 |
| FOXA1 SRX1961158 | T-47D Breast | 483 / 19934 (2.4%) | 13468 / 199340 (6.8%) | −157.9 | −156.0 | 0.36 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 409 / 19934 (2.1%) | 12280 / 199340 (6.2%) | −157.6 | −155.7 | 0.33 |
| FOSL2 SRX10475405 | A549 Lung | 181 / 19934 (0.9%) | 8294 / 199340 (4.2%) | −157.2 | −155.3 | 0.22 |
| NR3C1 SRX1672123 | BEAS-2B Lung | 309 / 19934 (1.6%) | 10599 / 199340 (5.3%) | −157.0 | −155.1 | 0.29 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 195 / 19934 (1.0%) | 8557 / 199340 (4.3%) | −157.0 | −155.1 | 0.23 |
| ESR1 SRX20282946 | MCF-7 Breast | 299 / 19934 (1.5%) | 10413 / 199340 (5.2%) | −156.5 | −154.6 | 0.29 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 273 / 19934 (1.4%) | 9959 / 199340 (5.0%) | −156.5 | −154.6 | 0.27 |
| KMT2A SRX2323891 | 293 Kidney | 1085 / 19934 (5.4%) | 4009 / 199340 (2.0%) | −156.5 | −154.6 | 2.71 |
| STAT3 SRX4192888 | MCF 10A Breast | 237 / 19934 (1.2%) | 9317 / 199340 (4.7%) | −156.4 | −154.5 | 0.25 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 426 / 19934 (2.1%) | 12512 / 199340 (6.3%) | −156.4 | −154.5 | 0.34 |
| FOXA1 SRX100477 | Hep G2 Liver | 566 / 19934 (2.8%) | 14682 / 199340 (7.4%) | −156.2 | −154.3 | 0.39 |
| MECOM SRX23677890 | HNT-34 Blood | 1986 / 19934 (10.0%) | 10018 / 199340 (5.0%) | −156.1 | −154.2 | 1.98 |
| RELA SRX7055007 | HAEC Cardiovascular | 875 / 19934 (4.4%) | 19166 / 199340 (9.6%) | −156.0 | −154.1 | 0.46 |
| RNF2 SRX18954702 | FaDu Others | 1085 / 19934 (5.4%) | 22051 / 199340 (11.1%) | −155.8 | −154.0 | 0.49 |
| ESR1 SRX371474 | BT-474 Breast | 229 / 19934 (1.1%) | 9150 / 199340 (4.6%) | −155.8 | −153.9 | 0.25 |
| WWTR1 SRX10119370 | MCF 10A Breast | 285 / 19934 (1.4%) | 10142 / 199340 (5.1%) | −155.7 | −153.8 | 0.28 |
| SMARCA4 SRX5982341 | A549 Lung | 137 / 19934 (0.7%) | 7373 / 199340 (3.7%) | −155.5 | −153.6 | 0.19 |
| NR3C1 SRX1672124 | BEAS-2B Lung | 349 / 19934 (1.8%) | 11223 / 199340 (5.6%) | −155.4 | −153.5 | 0.31 |
| DDIT3 SRX11379510 | Liposarcoma, Myxoid Adipocyte | 642 / 19934 (3.2%) | 15784 / 199340 (7.9%) | −155.2 | −153.3 | 0.41 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 172 / 19934 (0.9%) | 8056 / 199340 (4.0%) | −155.0 | −153.2 | 0.21 |
| EP300 SRX1012648 | MCF-7 Breast | 235 / 19934 (1.2%) | 9235 / 199340 (4.6%) | −154.9 | −153.0 | 0.25 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 618 / 19934 (3.1%) | 15413 / 199340 (7.7%) | −154.9 | −153.0 | 0.40 |
| ESR1 SRX20282953 | MCF-7 Breast | 412 / 19934 (2.1%) | 12228 / 199340 (6.1%) | −154.8 | −152.9 | 0.34 |
| ESR1 SRX10365532 | MCF-7 Breast | 277 / 19934 (1.4%) | 9954 / 199340 (5.0%) | −154.1 | −152.3 | 0.28 |
| FOSL2 SRX190224 | MCF-7 Breast | 169 / 19934 (0.8%) | 7972 / 199340 (4.0%) | −154.1 | −152.3 | 0.21 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 508 / 19934 (2.5%) | 13713 / 199340 (6.9%) | −154.0 | −152.1 | 0.37 |
| FOXA1 SRX3931032 | MCF-7 Breast | 287 / 19934 (1.4%) | 10112 / 199340 (5.1%) | −153.7 | −151.9 | 0.28 |
| ESR1 SRX20282971 | MCF-7 Breast | 496 / 19934 (2.5%) | 13511 / 199340 (6.8%) | −153.5 | −151.6 | 0.37 |
| AR SRX9109110 | MDA-MB-453 Breast | 916 / 19934 (4.6%) | 19631 / 199340 (9.8%) | −153.5 | −151.6 | 0.47 |
| TFAP2C SRX018833 | MCF-7 Breast | 451 / 19934 (2.3%) | 12794 / 199340 (6.4%) | −153.2 | −151.3 | 0.35 |
| GATAD2A SRX2636506 | Hep G2 Liver | 642 / 19934 (3.2%) | 15700 / 199340 (7.9%) | −153.1 | −151.2 | 0.41 |
| FOXL2 SRX6957477 | KGN Gonad | 512 / 19934 (2.6%) | 13741 / 199340 (6.9%) | −153.1 | −151.2 | 0.37 |
| ESR1 SRX2943589 | MCF-7 Breast | 257 / 19934 (1.3%) | 9562 / 199340 (4.8%) | −153.0 | −151.1 | 0.27 |
| ESR1 SRX371475 | BT-474 Breast | 256 / 19934 (1.3%) | 9545 / 199340 (4.8%) | −152.9 | −151.0 | 0.27 |
| SMARCA2 SRX5982361 | A549 Lung | 151 / 19934 (0.8%) | 7576 / 199340 (3.8%) | −152.7 | −150.8 | 0.20 |
| IRF3 SRX11453861 | Hep G2 Liver | 236 / 19934 (1.2%) | 123 / 199340 (0.1%) | −152.5 | −150.6 | 19.19 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 382 / 19934 (1.9%) | 11665 / 199340 (5.9%) | −152.4 | −150.6 | 0.33 |
| JUND SRX190303 | HCT 116 Digestive tract | 618 / 19934 (3.1%) | 15318 / 199340 (7.7%) | −152.4 | −150.5 | 0.40 |
| TFAP2C SRX128099 | MCF-7 Breast | 453 / 19934 (2.3%) | 12783 / 199340 (6.4%) | −152.0 | −150.1 | 0.35 |
| ERG SRX063921 | K-562 Blood | 1635 / 19934 (8.2%) | 7653 / 199340 (3.8%) | −151.9 | −150.1 | 2.14 |
| MECOM SRX23677891 | HNT-34 Blood | 1962 / 19934 (9.8%) | 9954 / 199340 (5.0%) | −151.9 | −150.0 | 1.97 |
| SMAD3 SRX148895 | LX2 Liver | 105 / 19934 (0.5%) | 6594 / 199340 (3.3%) | −151.8 | −149.9 | 0.16 |
| YAP1 SRX1038944 | IMR-90 Lung | 185 / 19934 (0.9%) | 8206 / 199340 (4.1%) | −151.7 | −149.8 | 0.23 |
| NR3C1 SRX19024866 | MCF-7 Breast | 170 / 19934 (0.9%) | 7918 / 199340 (4.0%) | −151.6 | −149.7 | 0.21 |
| KAT7 SRX101303 | RKO Digestive tract | 1399 / 19934 (7.0%) | 6078 / 199340 (3.0%) | −151.4 | −149.6 | 2.30 |
| FOXA1 SRX5323845 | MCF-7 Breast | 180 / 19934 (0.9%) | 8097 / 199340 (4.1%) | −151.3 | −149.4 | 0.22 |
| AR SRX9469988 | LAPC-4 Prostate | 669 / 19934 (3.4%) | 16024 / 199340 (8.0%) | −151.2 | −149.4 | 0.42 |
| FOSL2 SRX10475315 | Hep G2 Liver | 549 / 19934 (2.8%) | 14234 / 199340 (7.1%) | −151.1 | −149.2 | 0.39 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1349 / 19934 (6.8%) | 5759 / 199340 (2.9%) | −150.9 | −149.1 | 2.34 |
| FOS SRX3321961 | IMR-90 Lung | 254 / 19934 (1.3%) | 9436 / 199340 (4.7%) | −150.7 | −148.8 | 0.27 |
| ESR1 SRX5323873 | MCF-7 Breast | 616 / 19934 (3.1%) | 15217 / 199340 (7.6%) | −150.5 | −148.6 | 0.40 |
| CEBPB SRX2194248 | SUM 159PT Breast | 377 / 19934 (1.9%) | 11510 / 199340 (5.8%) | −150.3 | −148.5 | 0.33 |
| NR3C1 SRX10977364 | A549 Lung | 216 / 19934 (1.1%) | 8745 / 199340 (4.4%) | −150.3 | −148.5 | 0.25 |
| ESR1 SRX330070 | MCF-7 Breast | 264 / 19934 (1.3%) | 9600 / 199340 (4.8%) | −150.2 | −148.3 | 0.28 |
| CEBPB SRX190308 | HCT 116 Digestive tract | 462 / 19934 (2.3%) | 12859 / 199340 (6.5%) | −150.2 | −148.3 | 0.36 |
| AR SRX10820651 | LNCAP Prostate | 338 / 19934 (1.7%) | 399 / 199340 (0.2%) | −150.1 | −148.3 | 8.47 |
| ESR1 SRX10365533 | MCF-7 Breast | 242 / 19934 (1.2%) | 9202 / 199340 (4.6%) | −150.0 | −148.2 | 0.26 |
| FOXA1 SRX5323830 | T-47D Breast | 300 / 19934 (1.5%) | 10213 / 199340 (5.1%) | −150.0 | −148.1 | 0.29 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 645 / 19934 (3.2%) | 15624 / 199340 (7.8%) | −149.9 | −148.1 | 0.41 |
| SOX13 SRX2636248 | Hep G2 Liver | 694 / 19934 (3.5%) | 16337 / 199340 (8.2%) | −149.8 | −148.0 | 0.42 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 249 / 19934 (1.2%) | 9319 / 199340 (4.7%) | −149.8 | −147.9 | 0.27 |
| FOXA1 SRX5203294 | MCF-7 Breast | 142 / 19934 (0.7%) | 7309 / 199340 (3.7%) | −149.8 | −147.9 | 0.19 |
| BRD4 SRX612504 | LX2 Liver | 233 / 19934 (1.2%) | 9033 / 199340 (4.5%) | −149.6 | −147.8 | 0.26 |
| NR3C1 SRX10976922 | A549 Lung | 206 / 19934 (1.0%) | 8535 / 199340 (4.3%) | −149.6 | −147.7 | 0.24 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 611 / 19934 (3.1%) | 15098 / 199340 (7.6%) | −149.4 | −147.5 | 0.40 |
| CEBPB SRX7807101 | Unclassified Unclassified | 369 / 19934 (1.9%) | 11344 / 199340 (5.7%) | −149.4 | −147.5 | 0.33 |
| NR3C1 SRX1672127 | BEAS-2B Lung | 221 / 19934 (1.1%) | 8797 / 199340 (4.4%) | −149.1 | −147.3 | 0.25 |
| FOXA1 SRX3931073 | MCF-7 Breast | 299 / 19934 (1.5%) | 10168 / 199340 (5.1%) | −149.0 | −147.2 | 0.29 |
| EP300 SRX176883 | MCF-7 Breast | 235 / 19934 (1.2%) | 9043 / 199340 (4.5%) | −149.0 | −147.1 | 0.26 |
| ARID1A SRX5089388 | MCF-7 Breast | 257 / 19934 (1.3%) | 9433 / 199340 (4.7%) | −148.9 | −147.1 | 0.27 |
| EP300 SRX717859 | HeLa Uterus | 265 / 19934 (1.3%) | 9571 / 199340 (4.8%) | −148.8 | −147.0 | 0.28 |
| ZEB1 SRX13298924 | MCF-7 Breast | 240 / 19934 (1.2%) | 9129 / 199340 (4.6%) | −148.8 | −147.0 | 0.26 |
| ERG SRX063922 | K-562 Blood | 1700 / 19934 (8.5%) | 8175 / 199340 (4.1%) | −148.7 | −146.9 | 2.08 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 869 / 19934 (4.4%) | 18776 / 199340 (9.4%) | −148.6 | −146.8 | 0.46 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 260 / 19934 (1.3%) | 9472 / 199340 (4.8%) | −148.5 | −146.7 | 0.27 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 464 / 19934 (2.3%) | 866 / 199340 (0.4%) | −148.5 | −146.6 | 5.36 |
| MED1 SRX129090 | U-87 MG Neural | 509 / 19934 (2.6%) | 13514 / 199340 (6.8%) | −148.1 | −146.3 | 0.38 |
| FOXA1 SRX1447316 | MCF-7 Breast | 218 / 19934 (1.1%) | 8710 / 199340 (4.4%) | −148.1 | −146.3 | 0.25 |
| NKX2-1 SRX366170 | NCI-H441 Lung | 382 / 19934 (1.9%) | 11514 / 199340 (5.8%) | −148.1 | −146.3 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 213 / 19934 (1.1%) | 8616 / 199340 (4.3%) | −148.0 | −146.2 | 0.25 |
| NR3C1 SRX19024870 | MCF-7 Breast | 166 / 19934 (0.8%) | 7723 / 199340 (3.9%) | −147.8 | −145.9 | 0.21 |
Showing first 500 of 18913 rows.